AI won't fix medicine by speeding up drug pipelines, argues aging researcher Morgan Levine
DrMorganLevine · x · 2026-09-07
Aging researcher Dr. Morgan Levine argues the real bottleneck for AI in medicine isn't experiment pace or regulatory approval — it's that we haven't fundamentally rethought how we treat disease.
The dominant paradigm is still target → drug → clinical trial → approval. But most major chronic diseases, aging included, have no single cause or target, and cure attempts have largely failed. Even if AI massively accelerated this end-to-end pipeline, it wouldn't revolutionize human health.
Her case: AI should be used to confront biological complexity head-on and enable entirely new ways of treating disease, not just speed up the existing one.
More from AGI Musings
- Replit CEO on the 'self-driving company': agents to absorb coordination costs by 2030 — amasad · 2026-10-27
- US senator slams AI industry for proposing 50-death threshold for 'catastrophic incident' — peterwildeford · 2026-10-27
- Replit CEO Says AI Makes All Software De Facto Open Source; Aakash Gupta Asks What Moats Remain — aakashgupta · 2026-10-27
- Understanding the AI consciousness debate: which theory of mind is behind it — msharmas · 2026-10-27
- Functionalism: if consciousness is just what the brain computes, silicon can run it too — msharmas · 2026-10-27
- iPhone case with 85,000 reviews in days: everything fake in the age of abundance — tekbog · 2026-10-27